This is a randomized, double-blind, placebo-controlled, single-dose, dose escalation study in healthy male and or female subjects and subjects with Rheumatoid Arthritis (RA) to determine the safety and tolerability of MORAb-022.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01357759?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30
